(128 days)
No
The document describes image processing features (FICE, BLI, LCI) which are spectral and structural enhancements achieved through proprietary software, but there is no mention of AI or ML being used for these or any other functions. The performance studies focus on safety, biocompatibility, and basic image quality metrics, not AI/ML performance.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is intended for "treatment" in general abdominal, gynecologic, and thoracic areas.
Yes
The intended use explicitly states "diagnosis" for the Video Laparoscope EL-R740S, the VP-7000 unit, and the BL-7000 Light Source. Additionally, the VP-7000 unit features "adjunctive tools for gastrointestinal endoscopic examination" like BLI, LCI, and FICE which are used to supplement white light endoscopy, supporting a diagnostic function.
No
The device description clearly outlines hardware components such as a rigid insertion portion, cable portion, scope connector, optical system, CCD image sensor, electrical circuits, LED lamps, and physical housings for the video processor and light source. While software is mentioned for image processing and enhancement, it is integrated within these physical devices.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens (like blood, urine, or tissue) taken from the human body to provide information for diagnosis, monitoring, or screening.
- Device Function: The description clearly states that the FUJIFILM Video Laparoscope EL-R740S, VP-7000 Video Processor, and BL-7000 Light Source are used for in vivo (within the living body) observation, diagnosis, and treatment. They are inserted into the body to visualize internal structures and facilitate procedures.
- Lack of Specimen Analysis: There is no mention of the device analyzing any biological specimens taken from the patient. The VP-7000 processes electronic signals from the endoscope's camera, which is capturing images inside the body.
Therefore, the intended use and device description align with a medical device used for direct visualization and intervention within the body, not for analyzing samples outside the body, which is the hallmark of an IVD.
N/A
Intended Use / Indications for Use
FUJIFILM Video Laparoscope EL-R740S is intended to be used with a video processor, light source, monitor, hand instruments, electrosurgical unit and other ancillary equipment for minimally invasive observation, diagnosis and treatment in general abdominal, gynecologic and thoracic areas.
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video endoscope (a video camera in an endoscope). This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with monitor, recorder and various peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fujifilm white light endoscopy. BLI, LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The BL-7000 Light Source is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination. This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Product codes
GCJ, FET, NTN, NWB, PEA
Device Description
Video Laparoscope EL-R740S is comprised of a rigid insertion portion, cable portion, and scope connector. An optical system, CCD image sensor and electrical circuits are located within the distal end portion of the laparoscope. The video signal lines from the CCD sensor and the light quide fiber bundles are connected to the scope connector through the laparoscope.
Video Processor VP-7000 relays the image from the endoscope to a video monitor. Projection can be either analog or digital at the user's preference. The Processor incorporates internal digital storage capacity. VP-7000 also controls the light projected to the body cavity. VP-7000 provides for optional structural enhancement through user modes FICE, BLI-bright and LCI. Spectral and structural enhancements are achieved through proprietary software. The device is AC operated at a power setting of 100-240V/50-60Hz/0.8-0.5A. VP-7000 is housed in a steel polycarbonate case measuring 390x110x485mm.
The Fujinon/FUJIFILM endoscope employs fiber bundles to transmit light from Light Source BL-7000 to the body cavity. BL-7000 employs 4 LED lamps with a total power of 79.2W. Brightness control is performed by the user. The device is AC operated at a power setting of 100-240V/50-60Hz/1.2- 0.7A. BL-7000 is housed in a steel polycarbonate case measuring 390x155x485mm.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
general abdominal, gynecologic and thoracic areas.
gastrointestinal
Indicated Patient Age Range
all patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Electrical, laser, and photobiological safety of the subject device was evaluated using following standards: ANSI/AAMI ES60601-1:2012, IEC 60601-1-2:2014, IEC 60601-1-6:2013, IEC 60601-2-18:2009, IEC 60825-1:2007, and IEC 62471:2006.
Biocompatibility of the subject device was evaluated using the following consensus standards: ISO 10993-1:2018, ISO 10993-5:2009, ISO 10993-10:2010, and ISO 10993-11:2017. Biocompatibility testing was performed in accordance with FDA's guidance, "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process," published June 16, 2016.
Endoscope specific testing was conducted according to ISO 8600-1:2015.
Validation of the cleaning and sterilization instructions for the proposed device EL-R740S was performed in accordance with FDA's guidance, "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling," published March 17, 2015.
Software testing was conducted according to ANSVAAMI/IEC 62304:2006 and the FDA guidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices," published May 11, 2005. Cybersecurity controls were developed according to the FDA guidance, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices," published October 2, 2014.
The subject device was evaluated for color reproduction and image resolution. In both cases, the subject device demonstrated substantial equivalence to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
February 20, 2020
FUJIFILM Corporation % Jeffrey Wan Senior Regulatory Affairs Specialist FUJIFILM Medical Systems U.S.A., Inc. 81 Hartwell Avenue, Suite 300 Lexington, Massachusetts 02421
Re: K192918
Trade/Device Name: FUJIFILM Video Laparoscope EL-R740S. Video Processor VP-7000. Light Source BL-7000 Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: Class II Product Code: GCJ, FET, NTN, NWB, PEA Dated: January 24, 2020 Received: January 27, 2020
Dear Jeffrey Wan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Long Chen. Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K192918
Device Name
FUJIFILM Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000
Indications for Use (Describe)
FUJIFILM Video Laparoscope EL-R740S is intended to be used with a video processor, light source, monitor, hand instruments, electrosurgical unit and other ancillary equipment for minimally invasive observation, diagnosis and treatment in general abdominal, gynecologic and thoracic areas.
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video endoscope (a video camera in an endoscope). This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with monitor, recorder and various peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fujifilm white light endoscopy. BLI, LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The BL-7000 Light Source is used for endoscopic observation, diagnosis, treatment, and image recording, It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination. This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Type of Use (Select one or both, as applicable) | |
---|---|
Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED. |
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
K192918
510(k) SUMMARY FUJIFILM Corporation's Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000
Date: October 11, 2019
Submitter's Information:
FUJIFILM Corporation 798 Miyanodai Kaisei-Machi Ashigarakami-Gun, Kanagawa, 258-8538, Japan FDA Establishment Registration Number: 3001722928
Contact Person:
Jeffrey Wan Senior Regulatory Affairs Specialist Telephone: (201) 675-8947 E-Mail: jeffrey.wan@fujifilm.com
Identification of the Proposed Device:
| Proprietary/Trade Name: | FUJIFILM Video Laparoscope EL-R740S, Video Processor
VP-7000, and Light Source BL-7000 |
|-------------------------|-------------------------------------------------------------------------------------------|
| Common Name: | Laparoscope, Endoscopic Video Imaging System, LED Light
Source |
| Device Class: | Class II |
| Review Panel: | General & Plastic Surgery |
Classification Information:
Classification Name | CFR Section | Product Codes |
---|---|---|
Endoscope and accessories | 21 CFR 876.1500 | GCJ, FET, NTN, NWB, PEA |
Predicate Device:
- . EL-580FN Video Laparoscope (K162836)
- FUJIFILM Video Processor VP-7000 and Light Source BL-7000 (K163675) .
Reference Device:
- VP-4440FN Video Processor and XL-4450FN Light Source (K180414) .
- . FUJIFILM Endoscope Model EG-740N (K182836)
- EL2-TF410 Video Laparoscope (K983561) .
Intended Use / Indications for Use
FUJIFILM Video Laparoscope EL-R740S is intended to be used with a video processor, light source,
4
monitor, hand instruments, electrosurgical unit and other ancillary equipment for minimally invasive observation, diagnosis and treatment in general abdominal, gynecologic and thoracic areas.
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video camera in an endoscope). This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with monitor, recorder and various peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fujifilm white light endoscopy. BLI, LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The BL-7000 Light Source is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination. This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Device Description
Video Laparoscope EL-R740S is comprised of a rigid insertion portion, cable portion, and scope connector. An optical system, CCD image sensor and electrical circuits are located within the distal end portion of the laparoscope. The video signal lines from the CCD sensor and the light quide fiber bundles are connected to the scope connector through the laparoscope.
Video Processor VP-7000 relays the image from the endoscope to a video monitor. Projection can be either analog or digital at the user's preference. The Processor incorporates internal digital storage capacity. VP-7000 also controls the light projected to the body cavity. VP-7000 provides for optional structural enhancement through user modes FICE, BLI-bright and LCI. Spectral and structural enhancements are achieved through proprietary software. The device is AC operated at a power setting of 100-240V/50-60Hz/0.8-0.5A. VP-7000 is housed in a steel polycarbonate case measuring 390x110x485mm.
The Fujinon/FUJIFILM endoscope employs fiber bundles to transmit light from Light Source BL-7000 to the body cavity. BL-7000 employs 4 LED lamps with a total power of 79.2W. Brightness control is performed by the user. The device is AC operated at a power setting of 100-240V/50-60Hz/1.2- 0.7A. BL-7000 is housed in a steel polycarbonate case measuring 390x155x485mm.
Comparison of Technological Characteristics
Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000 differ from the predicate devices in terms of technological characteristics. The subject and predicate devices share the same mode of operation and intended use.
A summary of major differences between the subject and predicate devices is provided as follows:
5
Video Laparoscope EL-R740S
- Additional indication in the thoracic area .
- Compatibility with VP-7000 and BL-7000 .
- . Software is added to accommodate contactless optical communication to BL-7000.
- Material changes to the insertion portion
Video Processor VP-7000 and Light Source BL-7000
- Compatibility with FUJIFILM R700 system scopes ●
- Compatibility with optional camera control units .
- Software update to accommodate compatibility with R700 system scopes and othercamera . control units
Performance Data
Electrical, laser, and photobiological safety of the subject device was evaluated using following standards: ANSI/AAMI ES60601-1:2012, IEC 60601-1-2:2014, IEC 60601-1-6:2013, IEC 60601-2-18:2009, IEC 60825-1:2007, and IEC 62471:2006.
Biocompatibility of the subject device was evaluated using the following consensus standards: ISO 10993-1:2018, ISO 10993-5:2009, ISO 10993-10:2010, and ISO 10993-11:2017. Biocompatibility testing was performed in accordance with FDA's guidance, "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process," published June 16, 2016.
Endoscope specific testing was conducted according to ISO 8600-1:2015.
Validation of the cleaning and sterilization instructions for the proposed device EL-R740S was performed in accordance with FDA's guidance, "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling," published March 17, 2015.
Software testing was conducted according to ANSVAAMI/IEC 62304:2006 and the FDA guidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices," published May 11, 2005. Cybersecurity controls were developed according to the FDA guidance, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices," published October 2, 2014.
The subject device was evaluated for color reproduction and image resolution. In both cases, the subject device demonstrated substantial equivalence to the predicate device.
Substantial Equivalence
The subject devices FUJIFILM Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000 are substantially equivalent to the predicate devices, EL-580FN Video Laparoscope (K162836), Video Processor VP-7000 and Light Source BL-7000 (K163675). The subject and predicate devices share the same intended use and substantially similar indications. Bench testing demonstrates that the differences in technological characteristics and materials raise no new issues
6
of safety or effectiveness. Thus, FUJIFILM Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000 are substantially equivalent to the predicate devices.
Conclusions
The subject devices Video Laparoscope EL-R740S, Video Processor VP-7000, and Light Source BL-7000 are substantially equivalent to the predicate devices based on the same intended use, similar indications for use, and substantially equivalent technological characteristics and materials.